Rewolinski Melissa 4
4 · Arbutus Biopharma Corp · Filed Jul 13, 2023
Insider Transaction Report
Form 4
Rewolinski Melissa
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-07-12+110,000→ 110,000 totalExercise: $2.27Exp: 2033-07-12→ Common Shares (110,000 underlying)
Footnotes (2)
- [F1]Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on July 12, 2023, the date of the grant.
- [F2]The option will vest and become exercisable in three equal annual installments beginning one year from the grant date.